In this way, it brings together AR, the key driver of prostate cancer, and MDM2 (mouse double minute 2 gene), an E3 ubiquitin ligase leading to ubiquitination and subsequent degradation of f-AR and AR-V7 in prostate cancer cells. This evidence concerns the gene MDM2 and prostate carcinoma.